Mn(II)‐Aloe‐Emodin Nanoscale Coordination Polymer Enhances Ferroptosis by Synergistically Enhancing Reactive Oxygen Species Generation via the Nrf2–GPX4 Axis
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202400474 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Xiaoxin Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China. Hauptthemen laut MEDLINE: Ferroptosis, NF-E2-Related Factor 2, Reactive Oxygen Species, Manganese. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Fellowship Program of CPSF, CPSF.
Abstract (Originalsprache)
Ferroptosis induction is particularly promising for cancer therapy when the apoptosis pathway is compromised. Current strategies in nanomedicine for inducing ferroptosis primarily focus on promoting the accumulation of reactive oxygen species (ROS). However, the presence of intracellular antioxidants, such as nuclear factor erythroid 2‐related factor 2 (Nrf2), can limit the effectiveness of such therapy by activating detoxification systems and eliminating ROS. To overcome this challenge, we developed a synergistic ferroptosis‐inducing agent by modifying manganese (Mn 2+ )–1,8‐dihydroxy‐3‐hydroxymethyl‐anthraquinone (aloe‐emodin, AE) with polyvinyl pyrrolidone (PVP) to create nanoparticles (MAP NPs). In the tumor microenvironment, these NPs degraded and released AE and Mn(II), facilitating the generation of ROS and Mn(IV) through a Fenton‐like reaction between hydrogen peroxide (H 2 O 2 ) and Mn(II). Mn(IV) subsequently interacts with glutathione (GSH) to induce a cyclic catalytic effect, and the depletion of GSH diminished the activation of glutathione‐dependent peroxidase 4 (GPX4). Furthermore, AE inhibits the activity of Nrf2 and depleted GSH, thereby synergistically enhancing antitumor efficacy. Here it is demonstrated that MAP NPs effectively generate a robust ROS storm within tumor cells, suggesting that high‐performance ferroptosis therapy is effective. Additionally, the inclusion of Mn(II) in the MAP NPs enables real‐time monitoring of therapeutic efficacy via magnetic resonance T 1 ‐weighted contrast imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.
- Department of Radiology, Third Xiangya Hospital of Central South University, Changsha, 410013, China.
- Department of Biomedical Sciences College of Biology, Hunan University, Changsha, 410011, China.
- Siemens Healthineers MR Application China, Changsha, 410000, China.
Förderung
- National Natural Science Foundation of China
- Postdoctoral Fellowship Program of CPSF
- CPSF
- Clinical Research Center for Medical Imaging in Hunan Province
- Science and Technology Innovation program of Hunan Province
Zitieren
APA
Yang, X., Li, C., Ge, M., Li, X., Zhao, W., Guo, H., Nie, H., & Liu, J. (2024). Mn(II)‐Aloe‐Emodin Nanoscale Coordination Polymer Enhances Ferroptosis by Synergistically Enhancing Reactive Oxygen Species Generation via the Nrf2–GPX4 Axis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202400474
Vancouver
Yang X, Li C, Ge M, Li X, Zhao W, Guo H, et al. Mn(II)‐Aloe‐Emodin Nanoscale Coordination Polymer Enhances Ferroptosis by Synergistically Enhancing Reactive Oxygen Species Generation via the Nrf2–GPX4 Axis. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202400474
BibTeX
@article{Yang2024,
author = {Yang, Xiaoxin and Li, Chang and Ge, Mengjun and Li, Xiaoying and Zhao, Wei and Guo, Hu and Nie, Hemin and Liu, Jun},
title = {Mn(II)‐Aloe‐Emodin Nanoscale Coordination Polymer Enhances Ferroptosis by Synergistically Enhancing Reactive Oxygen Species Generation via the Nrf2–GPX4 Axis},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202400474}
}
EUVIMED